Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Evonik to Invest US$100 Million in Lafayette, Indiana, USA
Evonik has announced plans to invest US$100 million over five years to upgrade drug substance manufacturing infrastructure at its Tippecanoe Labs site in Lafayette, Indiana
BeOne Medicines to Invest US$300 Million in Hopewell, New Jersey, USA
BeOne Medicines has announced plans to invest US$300 million to expand its manufacturing and research and development site at the Princeton West Innovation Campus in Hopewell, New Jersey
Johnson & Johnson to Invest US$1 Billion in Jacksonville, Florida, USA
Johnson Johnson has announced plans to invest more than US$1 billion to expand vision manufacturing, packaging and distribution infrastructure in Jacksonville, Florida
Novartis to Invest US$23 Billion in Denton, Texas, USA
Novartis has announced plans to invest US$23 billion to establish a new radioligand therapy manufacturing facility in Denton, Texas
CSL to Invest US$1.5 Billion in Illinois, USA
CSL has announced an investment of US$15 billion to expand its plasmaderived therapies manufacturing facility in Kankakee, Illinois, USA
ESTEVE CDMO to Invest US$15.5 Million in Illinois, USA
ESTEVE CDMO has announced an investment of US$155 million to expand and upgrade its small molecule active pharmaceutical ingredient API manufacturing facility in Morton Grove, Illinois, USA
PharmaEssentia to Invest US$46 Million in Puerto Rico, USA
PharmaEssentia has announced an investment of approximately US$46 million to establish a new manufacturing facility in Toa Baja, Puerto Rico, USA
AbbVie to Invest US$380 Million in North Chicago, USA
AbbVie has announced an investment of US$380 million to construct two active pharmaceutical ingredient API manufacturing facilities at its North Chicago campus in Illinois, USA
Vetter Pharma to Invest US$530 million (€480 Million) in Saarlouis, Germany
Vetter Pharma has announced plans to invest approximately US$530 million 480 million in the first phase of a new commercial manufacturing facility in Saarlouis, Germany
Novo Nordisk to Invest over US$467 Million (€400 Million) in Athlone, Ireland
Novo Nordisk has announced plans to invest over US$467 million 400 million to expand its tablet manufacturing facility in Athlone, Ireland
